Nachrichten zur Eli Lilly & Co Aktie

Eli Lilly, up 24% YTD, looks to Q2 results beats

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Is Nektar Therapeutics Stock Surging Today?

Nektar Therapeutics Inc (NASDAQ: NKTR) said its former partner Eli Lilly And Co (NYSE: LLY) had presented "erroneous data" from two Phase 1b…

Nektar stock soars on new data for rezpeg after Eli Lilly got it wrong

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nektar Therapeutics sues Eli Lilly over autoimmune disease treatment

...Aug 7 (Reuters) - Nektar Therapeutics on Monday sued Eli Lilly......…

UPDATE 1-Nektar Therapeutics sues Eli Lilly over autoimmune disease treatment

...(Adds shares in paragraph 6, background throughout) Aug 7 (Reuters... not immediately respond to Reuters request for comment. Nektar......…

Nektar rallies on releasing new data for rezpeg after Eli Lilly got it wrong

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nektar Therapeutics’ stock jumps premarket after it says data presented by Eli Lilly for a skin treatment was incorrectly calculated

Nektar Therapeutics’ stock NKTR jumped 12.7% in premarket trade Monday, after the company said that efficacy data previously generated…

Eli Lilly Stock Is on a Tear. Expect More Gains After Earnings.

Despite its strong start to the year, the drugmaker’s report on Tuesday should lift shares even further....…

Eli Lilly: LIBRETTO-431 Study Meets Primary Endpoint

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Company (LLY) reported topline results from the LIBRETTO-431 study evaluating Retevmo versus platinum-based chemotherapy…

Eli Lilly reports positive results in trial of tretment for non-small cell lung cancer

Eli Lilly & Co. LLY said Friday a late-stage trial of a treatment for a type of non-small cell lung…

Dice Therapeutics gains amid Nasdaq delisting notice for Eli Lilly deal

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer: Bringen die Quartalsergebnisse den Turnaround?

Pharmawerte lagen die letzten Monate über eigentlich recht gut im Rennen und Titel wie Eli Lilly oder Vertex Pharmaceuticals führten…

Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials

The data bolsters Eli Lillys position in the budding weight loss drug market and establishes the company as a formidable…

Thursday’s Top Wall Street Analyst Upgrades and Downgrades: Alphabet, Eli Lilly, Etsy, Microsoft, Mosaic, NetApp, Omega Healthcare Investors, RTX, Spotify Technology, Walt Disney, WW International

Thursdays top analyst upgrades and downgrades included Alphabet, Eli Lilly, Etsy, Microsoft, Mosaic, NetApp, Omega Healthcare Investors, RTX, Sherwin-Williams, Spotify…

Adipositasmittel von Eli Lilly punktet in zwei Studien

Pharma - Der US-Pharmakonzern Eli Lilly sieht die Wirksamkeit seines neuen Abnehmmedikaments Tirzepatide durch zwei entscheidende Studien bestätigt....…

Is Eli Lilly Stock Still a Top-Growth Play?

The drugmaker may be running out of steam....…

Lilly Confirms Date and Conference Call for Second-Quarter 2023 Financial Results Announcement

INDIANAPOLIS, July 25, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2023 financial results on…

Eli Lilly extends tender offer to acquire Dice

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Lilly Extends Tender Offer To Acquire DICE Therapeutics

INDIANAPOLIS (dpa-AFX) - Drug manufacturer Eli Lilly and Co. (LLY) Tuesday announced the extension of its tender offer to acquire…

Lilly Announces Extension of Tender Offer to Acquire DICE

INDIANAPOLIS, July 25, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the extension of the expiration of…

Insiderhandel: Insider verkauft Aktien von Eli Lilly and Company im Wert von 275.773$

Lilly Endowment Inc - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2023-07-21...…

Warum Börsianer auf Eli Lilly und Novo Nordisk setzen statt auf Roche und Novartis

Investoren stürzen sich auf die Pharmaunternehmen, denen sie am meisten Wachstum zutrauen. Solche finden sie zurzeit nicht in der Schweiz....…

Lilly Joins Biogen as Alzheimer’s Drugs Finally Emerge

In trials, Biogen and Eli Lilly have shown that their drugs can slow early-stage decline in the disease. It could…

The Investing Clubs top 10 things to watch in the stock market Friday

Morgan Stanley now projects the global obesity market will reach $77 billion in 2030, with bullish implications for Club name…

Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Eli Lilly (LLY) closed at $451.20, marking a +0.91% move from the previous day....…

Biogen, Eli Lilly likely to split the Alzheimer’s drug market, analysts say

Eli Lilly and Co. LLY and Biogen Inc. BIIB are likely to reach an “equitable split” of the Alzheimer’s drug…

Is It Too Late to Buy Eli Lilly Stock?

Shares of the pharmaceutical giant are already up 36% this year....…

Eli Lilly: Donanemab bei Alzheimer wirksamer als gedacht, Aktie gibt nach

Auf der Suche nach einem Medikament gegen Alzheimer konnte der US-Pharmakonzern Eli Lilly einen Durchbruch bei Patienten im Frühstadium erzielen.…

Eli Lilly Says Alzheimers Treatment Slows Cognitive Decline

A Phase 3 trial shows that Eli Lilly's investigational Alzheimer’s treatment donanemab significantly slowed cognitive and functional decline in people in…

Eli Lilly (LLY) to Buy Versanis, Strengthen Obesity Portfolio

For the purchase of Versanis, Lilly (LLY) agrees to pay up to $1.93 billion in cash....…

Eli Lilly Alzheimers Treatment Donanemab Seen Slowing Cognitive, Functional Decline

Eli Lilly Alzheimer's Treatment Donanemab Seen Slowing Cognitive, Functional Decline...…

Eli Lilly expects FDA decision on Alzheimers treatment donanemab by the end of the year

Eli Lilly is racing to market donanemab for Alzheimers after Eisai and Biogens drug for the disease, Leqembi, won FDA…

Lilly-Medikament wirkt deutlich bei Alzheimer-Patienten im Frühstadium

Frankfurt (Reuters) - Das neue Alzheimer-Medikament des US-Pharmakonzerns Eli Lilly wirkt im Frühstadium der Krankheit offenbar besser als gedacht.

Bei…

Monday’s Top Wall Street Analyst Upgrades and Downgrades: Amazon, AT&T, Broadcom, DraftKings, Eli Lilly, General Mills, Microsoft, Nvidia, Plug Power and More

Mondays top analyst upgrades and downgrades included Amazon.com, AT&T, Broadcom, Corning, DraftKings, Eli Lilly, Fortinet, General Mills, Leslies, Microsoft, Nvidia,…

dpa-AFX ProFeed